Intravenous Immunoglobulin Market Outlook for Rare Disease Therapies
The global intravenous immunoglobulin (IVIG) market was valued at USD 14.9 billion in 2025 and is expected to reach USD 25.7 billion by 2033, expanding at a 7.0% CAGR from 2026 to 2033. The market is forecast to increase from USD 16.0 billion in 2026. North America accounted for the largest revenue share at 45.9% in 2025, while Asia Pacific is anticipated to register the fastest growth during...
0 Commentarii 0 Distribuiri 5 Views 0 previzualizare
Comunidad EDUCA https://comunidadeduca.com